Improving financial results throughout 2011 could provide additional upside in HDNG’s stock as the year progresses.
When SurModics divests its money-losing Pharmaceutical unit later this year, as I expect it will, profitability could continue to surprise to the upside.
Since the financial world is dominated by mathematics, in finance too, we are interested in the idea not the reality.
Streamline Health (STRM): Investing in New Management and the Growth of Healthcare Information Technology
Posted in Streamline Health (STRM), Summaries | Tagged Streamline Health Solutions, STRM
A new aggressive and entrepreneurial management team, coupled with strong growth in the electronic medical records, and healthcare information technology market, could boost the shares of STRM over the next few years.
Despite its penny share status, Lyris is a real company and a very well-known brand in the highly competitive email marketing software-as-a-service (SaaS) market. The stock looks like a good risk/reward here.
As JMBA’s transition to a franchise and licensing company accelerates in the coming quarters, the stock could get a boost.
With the improving auto market, and a major shift toward internally-generated leads in 2011, ABTL is again worth a look.
Posted in Intersections (INTX), Summaries | Tagged Intersections, INTX
Following the divestiture of a non-core business in 2010, INTX is now basically a pure-play in the vast and fast-growing identity theft market. Market recognition of continued improving financial results, accelerated growth in 2011, and some sort of a potential financial “recapitalization” in the next year, could boost the stock price further.